| Literature DB >> 34877196 |
Kruti J Yagnik1, Hala A Saad1, Helen L King1, Roger J Bedimo1, Christoph U Lehmann2, Richard J Medford1.
Abstract
Objective The need for clinicians to access Infectious Diseases (ID) consultants for clinical decision-making support increased during the Coronavirus Disease 2019 (COVID-19) pandemic. Traditional ID consultations with face-to-face (FTF) patient assessments are not always possible or practical during a pandemic and involve added exposure risk and personal protective equipment (PPE) use. Electronic consultations (e-consults) may provide an alternative and improve access to ID specialists during the pandemic. Methods We implemented ID e-consult platforms designed to answer clinical questions related to COVID-19 at three academic clinical institutions in Dallas, Texas. We conducted a retrospective review of all COVID-19 ID e-consults between March 16, 2020 and May 15, 2020 evaluating characteristics and outcomes of e-consults among the clinical sites. Results We completed 198 COVID-19 ID e-consults at participating institutions. The most common e-consult indications were for 63 (32%) repeat testing, 61 (31%) initial testing, 65 (33%) treatment options, and 61 (31%) Infection Prevention (IP). Based on the e-consult recommendation, 53 (27%) of patients were initially tested for COVID-19, 45 (23%) were re-tested, 44 (22%) of patients had PPE precautions initiated, and 37 (19%) had PPE precautions removed. The median time to consult completion was four hours and 8 (4%) consults were converted to standard FTF consults. Conclusion E-consult services can provide safe and timely access to ID specialists during the COVID-19 pandemic, minimizing the risk of infection to the patient and health care workers, while preserving PPE and testing supplies.Entities:
Keywords: covid-19 pandemic; infection control; infection prevention and control; infectious disease; virtual consult
Year: 2021 PMID: 34877196 PMCID: PMC8642131 DOI: 10.7759/cureus.19203
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Electronic Health Record reporting dashboard.
Patient characteristics of ID e-consult at each clinical site
ID: Infectious Diseases; e-consults: Electronic consultations; PCR: Polymerase chain reaction; COPD: Chronic obstructive pulmonary disease; CUH: Clements University Hospital; VA: Veterans Affairs.
| Clinical Site | |||||
| Patient characteristics | CUH n (%) | Parkland n (%) | VA n (%) | Total n (%) | P-value |
| Sex | |||||
| Female | 28 (41) | 44 (51) | 4 (9) | 76 (38) | p < 0.01 |
| Male | 40 (59) | 42 (49) | 40 (90) | 122 (62) | p < 0.01 |
| Age (mean [SD]) | 53 (16) | 52 (15) | 65 (13) | 55 (16) | p < 0.01 |
| Race/Ethnicity | |||||
| White | 34 (50) | 19 (22) | 26 (59) | 79 (40) | p < 0.01 |
| Black | 15 (22) | 12 (14) | 15 (34) | 42 (21) | p = 0.03 |
| Hispanic | 13 (19) | 55 (64) | 3 (7) | 71 (36) | p < 0.01 |
| Asian | 6 (9) | 0 (0) | 0 (0) | 6 (3) | p < 0.01 |
| Comorbidities | |||||
| Cardiac Condition | 13 (19) | 42 (49) | 34 (77) | 89 (45) | p < 0.01 |
| Diabetes mellitus | 12 (14) | 40 (47) | 17 (39) | 69 (39) | p < 0.01 |
| COPD or Asthma | 8 (12) | 11 (13) | 11 (25) | 30 (15) | p = 0.12 |
| End-stage renal disease | 3 (4) | 6 (7) | 2 (45) | 11(5) | p = 0.85 |
| Severe obesity | 0 (0) | 6 (7) | 3 (7) | 9 (4.5) | p = 0.04 |
| Liver disease | 3 (4) | 5 (6) | 6 (14) | 14 (7) | p = 0.18 |
| Immunocompromised | 20 (29) | 22 (26) | 12 (27) | 54 (27) | p = 0.74 |
| Resident of skilled nursing facility | 0 (0) | 12 (14) | 14 (32) | 26 (13) | p < 0.01 |
| SARS-CoV-2 PCR positive | 20 (29) | 36 (42) | 19 (43) | 75 (38) | p = 0.20 |
Definition of comorbidities listed for patient characteristics.
| Comorbidity | Definition |
| Cardiac condition | Hypertension, heart failure (systolic, diastolic, or both), coronary artery disease, or congenital heart disease |
| End-stage renal disease (ESRD) | On renal replacement therapy: hemodialysis (HD), peritoneal dialysis (PD), or continuous renal replacement therapy (CRRT) |
| Severe obesity | BMI ≥ 40 |
| Immunocompromised | HIV/AIDS, active malignancy, transplant recipient, or on chronic immunosuppressive medications (steroids, immunomodulators, etc.) |
| Liver disease | Cirrhosis, hepatitis, tumor (benign or malignant), autoimmune liver disease, or genetic liver disease |
ID e-consult characteristics at each clinical site.
IQR: Interquartile range; OB/GYN: Obstetrics and Gynecology; ID: Infectious Diseases; e-consult: Electronic consultations; FTF: Face-to-face.
| E-consult characteristics | CUH N (%) | Parkland N (%) | VA N (%) | Total N (%) | P-value |
| Total number of consults | 68 | 86 | 44 | 198 | |
| Ordering Department | |||||
| Inpatient | 45 (66) | 86 (100) | 44 (100) | 175 (88) | |
| Internal Medicine | 34 (76) | 71 (83) | 43 (98) | 148 (85) | |
| Medical ICU | 1 (2) | 2 (2) | 1 (2) | 4 (2) | |
| Surgical Service | 0 (0) | 5 (6) | 0 (0) | 5 (3) | |
| Oncology | 3 (6) | 1 (1) | 0 (0) | 4 (2) | |
| Neurology | 4 (9) | 1 (1) | 0 (0) | 5 (3) | |
| OB/GYN | 2 (4) | 3 (3) | 0 (0) | 5 (3) | |
| Psychiatry | 1 (2) | 1 (1) | 0 (0) | 2 (1) | |
| Other Inpatient | 0 (0) | 2(2) | 0 (0) | 2 (1) | |
| Outpatient | 23 (34) | 0 (0) | 0 (0) | 23 (12) | |
| Internal Medicine | 10 (43) | 10 (43) | |||
| Medical ICU | 0 (0) | 0 | |||
| Surgical Service | 6 (26) | 6 (26) | |||
| OB/GYN | 0 (0) | 0 | |||
| Psychiatry | 0 (0) | 0 | |||
| Oncology | 4 (17) | 4 (17) | |||
| Neurology | 3 (13) | 3 (13) | |||
| Other | 0 (0) | 0 | |||
| Time to Completion (median in (hours), IQR) | 4 (2-7.5) | 2 (1.25-4.75) | 5.5 (4-9.25) | 4 (2-7) | p < 0.01 |
| Converted to FTF (formal consult) | 0 (0) | 8 (9) | 0 (0) | 8 (4) | p < 0.01 |
Figure 2Reasons for e-consult, by hospital.
e-consults: Electronic consultations; CUH: Clements University Hospital; PHHS: Parkland Health and Hospital System; VA: Veterans Affairs.
Figure 3Reasons for e-consult, by week.
e-consults: Electronic consultations.
Figure 4Outcomes of e-consult, by hospital.
e-consults: Electronic consultations; CUH: Clements University Hospital; PHHS: Parkland Health and Hospital System; VA: Veterans Affairs.